Matinas Biopharma Files Prospectus For Offering $150M Mixed Shelf

Benzinga Newsdesk www.benzinga.com Neutral 93.4%

Neg 0% Neu 93.4% Pos 0%

https://www.sec.gov/Archives/edgar/data/1582554/000149315226028881/forms-3.htm

Comments

No comments yet. Be the first!